239 related articles for article (PubMed ID: 10357768)
1. p16(INK4a) and the control of cellular proliferative life span.
Huschtscha LI; Reddel RR
Carcinogenesis; 1999 Jun; 20(6):921-6. PubMed ID: 10357768
[TBL] [Abstract][Full Text] [Related]
2. Involvement of the INK4a/Arf gene locus in senescence.
Collins CJ; Sedivy JM
Aging Cell; 2003 Jun; 2(3):145-50. PubMed ID: 12882406
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of p19(Arf) and p16(Ink4a) loss on senescence of murine bone marrow-derived preB cells and macrophages.
Randle DH; Zindy F; Sherr CJ; Roussel MF
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9654-9. PubMed ID: 11481442
[TBL] [Abstract][Full Text] [Related]
4. E2FBP1 antagonizes the p16(INK4A)-Rb tumor suppressor machinery for growth suppression and cellular senescence by regulating promyelocytic leukemia protein stability.
Fukuyo Y; Takahashi A; Hara E; Horikoshi N; Pandita TK; Nakajima T
Int J Oral Sci; 2011 Oct; 3(4):200-8. PubMed ID: 22010578
[TBL] [Abstract][Full Text] [Related]
5. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells.
Oruetxebarria I; Venturini F; Kekarainen T; Houweling A; Zuijderduijn LM; Mohd-Sarip A; Vries RG; Hoeben RC; Verrijzer CP
J Biol Chem; 2004 Jan; 279(5):3807-16. PubMed ID: 14604992
[TBL] [Abstract][Full Text] [Related]
6. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.
Dickson MA; Hahn WC; Ino Y; Ronfard V; Wu JY; Weinberg RA; Louis DN; Li FP; Rheinwald JG
Mol Cell Biol; 2000 Feb; 20(4):1436-47. PubMed ID: 10648628
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase.
Farwell DG; Shera KA; Koop JI; Bonnet GA; Matthews CP; Reuther GW; Coltrera MD; McDougall JK; Klingelhutz AJ
Am J Pathol; 2000 May; 156(5):1537-47. PubMed ID: 10793065
[TBL] [Abstract][Full Text] [Related]
8. Tumor suppressors and oncogenes in cellular senescence.
Bringold F; Serrano M
Exp Gerontol; 2000 May; 35(3):317-29. PubMed ID: 10832053
[TBL] [Abstract][Full Text] [Related]
9. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1.
Itahana K; Zou Y; Itahana Y; Martinez JL; Beausejour C; Jacobs JJ; Van Lohuizen M; Band V; Campisi J; Dimri GP
Mol Cell Biol; 2003 Jan; 23(1):389-401. PubMed ID: 12482990
[TBL] [Abstract][Full Text] [Related]
10. p16(Ink4a) in melanocyte senescence and differentiation.
Sviderskaya EV; Hill SP; Evans-Whipp TJ; Chin L; Orlow SJ; Easty DJ; Cheong SC; Beach D; DePinho RA; Bennett DC
J Natl Cancer Inst; 2002 Mar; 94(6):446-54. PubMed ID: 11904317
[TBL] [Abstract][Full Text] [Related]
11. Role of INK4a/Arf locus-encoded senescent checkpoints activated in normal and psoriatic keratinocytes.
Chaturvedi V; Cesnjaj M; Bacon P; Panella J; Choubey D; Diaz MO; Nickoloff BJ
Am J Pathol; 2003 Jan; 162(1):161-70. PubMed ID: 12507899
[TBL] [Abstract][Full Text] [Related]
12. Parsing Ink4a/Arf: "pure" p16-null mice.
Sherr CJ
Cell; 2001 Sep; 106(5):531-4. PubMed ID: 11551500
[No Abstract] [Full Text] [Related]
13. Frequent alterations of the p14(ARF) and p16(INK4a) genes in primary central nervous system lymphomas.
Nakamura M; Sakaki T; Hashimoto H; Nakase H; Ishida E; Shimada K; Konishi N
Cancer Res; 2001 Sep; 61(17):6335-9. PubMed ID: 11522621
[TBL] [Abstract][Full Text] [Related]
14. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
15. Involvement of Bmi-1 gene in the development of gastrointestinal stromal tumor by regulating p16
Wang JL; Wu JH; Hong C; Wang YN; Zhou Y; Long ZW; Zhou Y; Qin HS
Pathol Res Pract; 2017 Dec; 213(12):1542-1551. PubMed ID: 29042141
[TBL] [Abstract][Full Text] [Related]
16. Quantitative real-time PCR does not show selective targeting of p14(ARF) but concomitant inactivation of both p16(INK4A) and p14(ARF) in 105 human primary gliomas.
Labuhn M; Jones G; Speel EJ; Maier D; Zweifel C; Gratzl O; Van Meir EG; Hegi ME; Merlo A
Oncogene; 2001 Mar; 20(9):1103-9. PubMed ID: 11314047
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
Pare R; Shin JS; Lee CS
Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
[TBL] [Abstract][Full Text] [Related]
18. [Cyclin dependent kinase inhibitors and replicative senescence].
Gerland LM; Ffrench M; Magaud JP
Pathol Biol (Paris); 2001 Dec; 49(10):830-9. PubMed ID: 11776695
[TBL] [Abstract][Full Text] [Related]
19. The INK4A/ARF locus: role in cell cycle control and apoptosis and implications for glioma growth.
Ivanchuk SM; Mondal S; Dirks PB; Rutka JT
J Neurooncol; 2001 Feb; 51(3):219-29. PubMed ID: 11407594
[TBL] [Abstract][Full Text] [Related]
20. p16INK4a-induced senescence is disabled by melanoma-associated mutations.
Haferkamp S; Becker TM; Scurr LL; Kefford RF; Rizos H
Aging Cell; 2008 Oct; 7(5):733-45. PubMed ID: 18843795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
